Julia Chapman
Corporate Officer/Principal presso BridgeBio Pharma LLC
Profilo
Julia Chapman is currently working as the Vice President of Business Development & Strategy at BridgeBio Pharma LLC.
Previously, she worked as the Senior Vice President of Corporate Strategy & Planning at Verve Therapeutics, Inc. Ms. Chapman completed her undergraduate degree and earned an MBA from Duke University.
Posizioni attive di Julia Chapman
Società | Posizione | Inizio |
---|---|---|
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Precedenti posizioni note di Julia Chapman
Società | Posizione | Fine |
---|---|---|
VERVE THERAPEUTICS, INC. | Corporate Officer/Principal | - |
Formazione di Julia Chapman
Duke University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
VERVE THERAPEUTICS, INC. | Health Technology |
Aziende private | 1 |
---|---|
BridgeBio Pharma LLC
BridgeBio Pharma LLC BiotechnologyHealth Technology BridgeBio Pharma LLC engages in the discovery and development of pharmaceutical drugs for patients with genetic diseases. It offers transthyretin stabilizer, SHP2 inhibitor, KRAS inhibitor, Collagen 7 replacement, and S1P-lyase inhibitor. The company was founded by Neil Kumar and is headquartered in Palo Alto, CA. | Health Technology |
- Borsa valori
- Insiders
- Julia Chapman